References
- Adelberg DE, Bishop MR. Emergencies related to cancer chemotherapy and
hematopoietic stem cell transplantation. Emerg Med Clin North
Am.2009;27:311-31
- Bodey GP, Buckley, M, Sathe YS, Freireich EJ. (1966) Quantative
relationships between circulating leukocytes and infection in patients
with acute leukemia. Ann Intern Med 64:328-40
- Wenneras C, Hagberg L, Andersson R, Hynsjö L, Lindahl A, Okroj M, Blom
AM, Johansson P, Andreasson B, Gottfries J et al. Distinct
Inflammatory Mediator Patterns Characterize Infectious and Sterile
Systemic Inflammation in Febrile Neutropenic Hematology Patients, Open
Access, www.plosone.org, March 2014, 9 (3), e92319
- Bille J. Laboratory diagnosis of infections in febrile neutropenic or
immunocompromised patients. Int J Antimicrob Agents.2000;16(2):87-9
- Mulinde J, Joshi M. The diagnostic and therapeutic approach to lower
respiratory tract infections in the neutropenic patient. J Antimicrob
Chemother.1998;41(suppl D):51-5
- Juutialinen A, Hamalainen S, Pulkki K Kuittinen T, Nousiainen T,
Koivula I. Biomarkers for bacteremia and severe sepsis in
hematological patients with neutropenic fever: multivariate logistic
regression analysis and factor analysis. Leuk Lymphoma,
2011;52:2349-55
- Buyukberber N, Buyukberber S, Sevinc A, Camci C. Cytokine
concentrations are not predictive of bacteremia in febrile neutropenic
patients. Med Oncol.2009;26:55-61doi:10.1007/s12032-008-9081-z
- Persson L, Engervall P, Magnuson A, Vikerfors T, Söderquist B, Hansson
LO, Tidefelt U. Use of inflammatory markers for early detection of
bacteraemia in patients with febrile neutropenia. Scand J Infect Dis
2004;36:365-71.doi:10.1080/00365540410020217
- Kern WV, Heiss M, Steinbach G. Prediction of gram-negative bacteraemia
in patients with cancer and febrile neutropenia by means of IL-8
levels in serum: targeting empirical monotherapy versus combination
therapy. Clin Infect Dis.2001;32:832-35.doi:10.1086/319207
- Erel O, Neselioglu S (2014) A novel and automated assay for
thiol/disulphide homeostasis. Clin Biochem 47:326–332
- Wasterlain CG, Fujikawa DG, Penix L, Sankar R (1993)
Pathophysiological mechanisms of brain damage from status epilepticus.
Epilepsia 34:37–53
- Horton JW. Free radicals and lipid peroxidation mediated injury in
burn trauma: The role of antioxidant therapy. Toxicology
2003;189(1-2):75-88
- Ellman G, Lysko H. A precise method for the determination of whole
blood and plasma sulfhydryl groups. Anal Biochem. 1979;93:98–102
- Sudhoff T, Giagounidis A, Karthaus M, Serum and plasma parameters in
clinical evaluation of neutropenic fever Antibiot Chemother,
2000,50;10-19
- Carrol ED, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis.
Int J Antimicrob Agents.2002;20(1):1-9
- Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R,
Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott J. The
multinational association for supportive care in cancer risk index: a
multinational scoring system for identifying low-risk febrile
neutropenic cancer patients. J Clin Oncol, 2000, 18(16):3038-51
- Carmona-Bayonas A, Jimenez-Fonseca B, Virizuela Echaburu J, Antonio M,
Font C, Boisca M, Ramchandani A, Martinez J, Hernando Cubero J,
Espinosa J et al. Prediction of serious complications in patients with
seemingly stable febrile neutropenia: validation of the Clinical Index
of Stable Febrile Neutropenia in a prospective cohort of patients from
the FINITE study. J Clin Onc,2015 33(5):465-71
- Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad
II, Rolston KV, Young JA, Wingard JR .Clinical Practice Guideline for
the Use of Antimicrobial Agents in Neutropenic Patients with Cancer:
2010 Update by the Infectious Diseases Society of America, e56 d CID
2011:52 (15 February)
- De Naurois J, Novitzky-Basso I, Gill MJ, Marti FM, Cullen MH, Roila F;
Management of febrile neutropenia: ESMO clinical practice guidelines.
Ann Oncol,2000,21(suppl 5):252-56,doi:10.1093/annonc/mdq196
- LeGrand A, Fermor B, Fink C, Pisetsky DS, Weinberg JB, Vail TP, Guilak
F. Interleukin-1, tumor necrosis factor alpha, and interleukin-17
synergistically up-regulate nitric oxide and prostaglandin E2
production in explants of human osteoarthritic knee menisci. Arthritis
Rheum 2001;44(9):2078-83
- Groitl B, Jakob U. Thiol-based redox switches. Biochim Biophys Acta
2014;1844:1335–1343
- Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogesang H, Junker U,
Jager L, Reinhart K. Procalcitonin expression in human peripheral
blood mononuclear cells and its modulation by lipopolysaccharides and
sepsis-related cytokines in vitro.J Lab Clin Med,1999,134;49-55
- Meisner M, Muller V, Khakpour Z, Toegel E, Redl H. Induction of
procalcitonin and proinflammatory cytokines in an anhepatic baboon
endotoxin shock model.Shock,2003,19:187-90
- Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin
Chim Acta.2002;323(1-2):17-29
- Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K. The role of
procalcitonin in febrile neutropenic patients: review of the
literature. Infection,
2008,36(5):396-407.doi:10.1007/s15010-008-7374-y
- Wu CW, Wu JY, Chen CK, Huang SL, Hsu SC, Lee MT, Chang SS, Lee CC.
Does procalcitonin, C-reactive protein, or interleukin-6 test have a
role in the diagnosis of severe infection in patients with febrile
neutropenia? A systematic review and meta-analysis. Support Care
Cancer,2015;23:2863-72
- Luz Fiusa MM, Costa Lima C, de Souza GR, Vigorito AC, Penteado Aranha
FJ, Lorand-Metze I, Annichino-Bizzacchi JM, de Souza CA, De Paula EV.
A high angiopoetin2/angiopoetin1 ratio is associated with a high risk
of septic shock in patients with febrile neutropenia. Crit Care
2013;17:R169
- Alves BE, Montalvao SA, Aranha FJ Siegl TF, Souza CA, Lorand-Metze I,
Annichino-Bizzacchi JM, De Paula EV. Imbalances in serum angiopoetin
concentrations are early predictors of septic shock development in
patients with post chemotherapy febrile neutropenia. BMC Infect Dis
2010;10:143
- Ruokonen E, Nousiainen T, Pulkki K, Takala J. Procalcitonin
concentrations in patients with neutropenic fever. Eur J Clin
Microbiol Infect Dis,1999,18(4);283-85
- Dulisse B, Li X, Gayle JA, Barron RL, Ernst FR, Rothman KJ, Legg JC,
Kaye JA. A retrospective study of the clinical and economic burden
during hospitalizations among cancer patients with febrile
neutropenia. J Med Econ.2013;16 (6):720-35. doi:
10.3111/13696998.2013.782034
- Yetkin F, Senol E, Yalçın S, Haznedar R. The Evaluation of
Procalcitonin as a Diagnostic and Prognostic Marker of Bacterial
Infections in Febrile Neutropenic Patients. Klimik Dergisi
2011;24(1):24-30
- Coyne JC,BS Le Vivian, Brennan JJ, Castillo EM, Shatsky RA, Ferran K,
Brodine S, Vilke GM . Application of the MASCC and CISNE
Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic
Patients in the Emergency Department. Annals of Emergency
Medicine,Volume 69,No:6:June 2017
- Rast AC, Kutz A, Felder S, Faessler L, Steiner D, Laukemann S, Haubitz
S, Huber A, Buergi U, Conca A. Procalcitonin Improves the Glasgow
Prognostic Scale for Outcome Prediction in Emergency Patients with
Cancer: a Cohort Study, Dis Markers, 2015, E Pub
- Sedef AM, Köse F, Mertsoylu H, Ozyılkan O. Procalcitonin as a
biomarker for infection related mortality in cancer patients. Curr
Opin Support Pall Care,2015;9:168-73
- Massaro KSR, Macedo R, de Castro BS, Dulley F, Oliveira MS, Yasuda MA,
Levin AS, Costa SF. Risk factor for death in hematopoietic stem cell
transplantation: are biomarkers useful to forsee the prognosis in this
population of patients? Infection 2014,42:1023-32
- Ortega M, Rovira M, Almela M, de la Bellacasa JP, Carreras E, Mensa J
. Measurement of C-reactive protein in adults with febrile neutropenia
after hematopoietic cell transplantation. Bone Marrow Transplantation
2004;33:741-44
- Ahn S, Lee YS, Lee JL, Lim KS, Yoon SC. A new prognostic model for
chemotherapy-induced febrile neutropenia. Int J Clin
Oncol.2016:21:46-52
- Ha YE, Song JH, Kang WK, Peck KR, Chung DR, Kang CI, Joung MK, Joo EJ,
Shon KM. Clinical factors predicting bacteremia in low-risk febrile
neutropenia after anti-cancer chemotherapy. Support Care
Cancer.2011;19:1761-67
- Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro
M, Herrstedt J. Management of febrile neutropenia : ESMO Clinical
Practice Guidelines. Ann Oncol. 2016:27;111-118
- Combariza JF, Lombana M, Pino EL, Arango M. C-reactive protein and the
MASCC risk index identify high-risk patients with febrile neutropenia
and hematologic neoplasms. Support Care Cancer 2015, 23:1009-13
- Uys A, Rapoport BL, Fickl H, Meyer PW, Anderson R. Prediction of
outcome in cancer patients with febrile neutropenia: comparison of the
Multinational Association of Supportive Care in Cancer risk-index
score with procalcitonin C-reactive protein, serum amyloid A, and
interleukins-1β,-6,-8 and 10 European Journal of Cancer
Care,2007;16:475-483
- Ahn S, Lee YS, Lim KS, Lee JL. Adding procalcitonin to the MASCC
risk-index score could improve risk stratification of patients with
febrile neutropenia. Support Care Cancer, 2013,21:2303-08
- Klastersky J,Ameye L, Maertens J, Georgala A, Muanza F, Aoun M,
Ferrant A, Rapoport B, Rolston K, Paesmans M. Bacteraemia in febrile
neutropenic cancer patients. Int J Antimicrob Agents.2007:30 (suppl
1):51-9
- Viscoli C, Cometta A, Kern WV, Bock R, Paesmans M, Crokaert F, Glauser
MP, Calandra T . Piperaccilin-tazobactam monotherapy in high risk
febrile neutropenic cancer patients. Clin Microbiol Infect
2006;12:212-16
- Rintala E, Irjala K, Nikoskelainen J. Value of measurement of
C-reactive protein in febrile patients with hematological
malignancies. Eur J Clin Microbiol Infect Dis 1992;11:973-78
- Kern WV. Risk assessment and treatment of low risk patients with
febrile neutropenia. Clin Infect Dis 2006;42:533-40
- Prat C,Sancho MJ, Dominguez J, Xicoy B, Gimenez M, Ferra C, Blanco S,
Lacoma A, Ribera JM, Ausina V. Evaluation of procalcitonin, neopterin,
C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection
in patients with febrile neutropenia. Leukemia and Lymphoma, 2008
September;49(9):1752-61
Table 1. The
Multinational Association for Supportive Care in Cancer (MASCC) Score